Palmieri G, Perego M, Alkabes M, Palmieri R
Ric Clin Lab. 1979 Jul-Sep;9(3):253-63. doi: 10.1007/BF02932177.
The results obtained from a research on 100 patients of both sexes affected with bronchial asthma, chronic obstructive bronchopathy, rheumatoid arthritis, haematological disorders and some other pathological forms, all depending on steroid therapy, are reported in this paper. The treatment was carried out using a new chronopluricorticoid (Dutimelan 8 15). The clinical efficiency is comparable to that obtained by the traditional steroid treatment with the advantage that symptoms of hypercorticism were absent or insignificant. The authors believe that such excellent results are to be attributed to the particular chronopharmacological characteristics of this preparation.
本文报道了对100例患有支气管哮喘、慢性阻塞性支气管病、类风湿性关节炎、血液系统疾病及其他一些病理形式的男女患者进行的一项研究结果,所有这些疾病都依赖于类固醇治疗。治疗使用了一种新型的时辰加皮质激素(Dutimelan 8 15)。临床疗效与传统类固醇治疗相当,优点是不存在或仅有轻微的皮质功能亢进症状。作者认为,如此优异的结果归因于该制剂特殊的时辰药理学特性。